Insider Buying: Creo Medical Group PLC (LON:CREO) Insider Purchases 4,712 Shares of Stock

Creo Medical Group PLC (LON:CREO) insider Richard John Rees purchased 4,712 shares of Creo Medical Group stock in a transaction dated Thursday, January 16th. The stock was bought at an average cost of GBX 19 ($0.23) per share, with a total value of £895.28 ($1,102.15).

Richard John Rees also recently made the following trade(s):

• On Thursday, October 24th, Richard John Rees bought 98,000 shares of Creo Medical Group stock. The stock was bought at an average price of GBX 20 ($0.25) per share, for a total transaction of £19,600 ($24,129.02).

Creo Medical Group Stock Performance

CREO stock opened at GBX 17.45 ($0.21) on Thursday. Creo Medical Group PLC has a one year low of GBX 12 ($0.15) and a one year high of GBX 43 ($0.53). The firm has a market cap of £63.13 million, a price-to-earnings ratio of -290.83 and a beta of 0.86. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24. The firm has a 50-day simple moving average of GBX 17.54 and a two-hundred day simple moving average of GBX 23.40.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.